Company intelligence / Profile preview

Biovion Pharma

Vaijapur, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

Biovion Pharma is an Indian private pharmaceutical company that appears to market a portfolio of commercial, primarily small-molecule generic medicines. Public product-listing sources associate the company with tablets, capsules, and creams spanning cardiovascular, metabolic, anti-infective, gastrointestinal, pain, and dermatology categories. Available evidence suggests it is an operating commercial-stage pharma marketer/manufacturer rather than a clinical-stage biotech developer. There is no clear evidence of a proprietary R&D pipeline, novel therapeutic platform, or named drug-development programs in clinical trials.

Therapeutic areas: ImmunologyEndocrinologyCardiovascularNeurologyInfectious DiseasesGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Biovion Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biovion Pharma.

Explore the full profile